About Enhancer

Enhancer ID: E_02_0911
Species: human
Position : chr8:128709135-128745673
Biosample name:
Experiment class : Low+High throughput
Enhancer type: Enhancer
Disease: Endometrial cancer
Pubmed ID:  24512546
Enhancer experiment: ChIP,ChIP-PCR,ChIP-seq,qRT-PCR
Enhancer experiment description: Interestingly, we showed that FOXA1 and AR more evidently bound to the MYC enhancer regions as compared to MYC promoter regions. These results could be attributed to other co-regulators involved in this binding process. Since TCF7L2, a protein mediating DNA looping for long-distance interactions of distal en_x0002_hancers and proximal promoters, physically interacts with FOXA1 and AR and mediates the transcription of MYC in breast cancer [19], future investigation will be needed to clarify which co-regulators are involved in FOXA1/AR binding to the enhancer regions upstream of MYC in EC cells.

About Target gene

Target gene : MYC(MRTLC,bHLHe39,c-Myc),MYC(MRTLC,bHLHe39,c-Myc)
Strong evidence: --
Less strong evidence: ChIP,ChIP-PCR,qRT-PCR
Target gene experiment description: Our ChIP assays showed that both FOXA1 and AR could bind to all the five putative FOXA1-AR-binding regions in MFE-296 cells. More_x0002_over, both FOXA1 and AR bound most greatly to the Enh-1 (enhancer 1) region among the five binding regions (Figure 4D). Our ChIP data together with our co_x0002_immunoprecipitation data suggested that FOXA1 forming protein complex with AR might bind to FOXA1-AR over_x0002_lapping binding regions upstream of MYC, leading to MYC activation in EC cells.;Our ChIP assays showed that both FOXA1 and AR could bind to all the five putative FOXA1-AR-binding regions in MFE-296 cells. More_x0002_over, both FOXA1 and AR bound most greatly to the Enh-1 (enhancer 1) region among the five binding regions (Figure 4D). Our ChIP data together with our co_x0002_immunoprecipitation data suggested that FOXA1 forming protein complex with AR might bind to FOXA1-AR over_x0002_lapping binding regions upstream of MYC, leading to MYC activation in EC cells.

About TF

TF name : FOXA1(HNF3A,TCF3A)AR(AIS8,DHTR,HUMARA,HYSP1,KD,NR3C4,SBMA,SMAX1,TFM,AR)FOXA1(HNF3A,TCF3A)AR(AIS8,DHTR,HUMARA,HYSP1,KD,NR3C4,SBMA,SMAX1,TFM,AR)
TF experiment: ChIP,ChIP-PCR,ChIP-seq,qRT-PCR
TF experiment description: Our ChIP assays showed that both FOXA1 and AR could bind to all the five putative FOXA1-AR-binding regions in MFE-296 cells. More_x0002_over, both FOXA1 and AR bound most greatly to the Enh-1 (Enhancer 1) region among the five binding regions.;Our ChIP assays showed that both FOXA1 and AR could bind to all the five putative FOXA1-AR-binding regions in MFE-296 cells. More_x0002_over, both FOXA1 and AR bound most greatly to the Enh-1 (Enhancer 1) region among the five binding regions.

About Function

Enhancer function : --
Enhancer function experiment: --
Enhancer function
experiment description:
--

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
AR Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 reactome 65
AR Alpha6Beta4Integrin netpath 74
AR AndrogenReceptor netpath 167
AR Coregulation of Androgen receptor activity pid 61
AR FOXA1 transcription factor network pid 45
AR IL6 netpath 85
AR Nongenotropic Androgen signaling pid 31
AR Notch-mediated HES/HEY network pid 48
AR Nuclear Receptor transcription pathway reactome 51
AR Regulation of Androgen receptor activity pid 54
AR Regulation of nuclear beta catenin signaling and target gene transcription pid 80
AR Regulation of nuclear SMAD2/3 signaling pid 82
AR TGF_beta_Receptor netpath 220
AR Oocyte meiosis kegg 110
AR Pathways in cancer kegg 321
AR Prostate cancer kegg 85
AR Hs_DNA_Damage_Response_WP707_82937 wikipathways 28
AR Hs_miRNA_Regulation_of_DNA_Damage_Response_WP1530_84694 wikipathways 28
AR Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 wikipathways 122
AR Hs_Sudden_Infant_Death_Syndrome_(SIDS)_Susceptibility_Pathways_WP706_86078 wikipathways 33
AR Hs_Androgen_receptor_signaling_pathway_WP138_79958 wikipathways 27
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
AR Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 reactome 65
AR Alpha6Beta4Integrin netpath 74
AR AndrogenReceptor netpath 167
AR Coregulation of Androgen receptor activity pid 61
AR FOXA1 transcription factor network pid 45
AR IL6 netpath 85
AR Nongenotropic Androgen signaling pid 31
AR Notch-mediated HES/HEY network pid 48
AR Nuclear Receptor transcription pathway reactome 51
AR Regulation of Androgen receptor activity pid 54
AR Regulation of nuclear beta catenin signaling and target gene transcription pid 80
AR Regulation of nuclear SMAD2/3 signaling pid 82
AR TGF_beta_Receptor netpath 220
AR Oocyte meiosis kegg 110
AR Pathways in cancer kegg 321
AR Prostate cancer kegg 85
AR Hs_DNA_Damage_Response_WP707_82937 wikipathways 28
AR Hs_miRNA_Regulation_of_DNA_Damage_Response_WP1530_84694 wikipathways 28
AR Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 wikipathways 122
AR Hs_Sudden_Infant_Death_Syndrome_(SIDS)_Susceptibility_Pathways_WP706_86078 wikipathways 33
AR Hs_Androgen_receptor_signaling_pathway_WP138_79958 wikipathways 27

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs